These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4717370)
1. [Biological bases for a fluoride treatment of otospongiosis. Experimental and clinical results]. Causse J; Chevance LG Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):139-60. PubMed ID: 4717370 [No Abstract] [Full Text] [Related]
2. Enzymology of otospongiosis and NaF therapy. Causse JR; Shambaugh GE; Causse B; Bretlau P Am J Otol; 1980 Apr; 1(4):206-14. PubMed ID: 6969991 [No Abstract] [Full Text] [Related]
3. Clinical experience and experimental findings with sodium fluoride in otosclerosis (otospongiosis). Causse J; Chevance LG; Shambaugh GE Ann Otol Rhinol Laryngol; 1974; 83(5):643-7. PubMed ID: 4412470 [No Abstract] [Full Text] [Related]
4. [What may be expected from the therapy of otosclerosis using sodium fluoride?]. Chládek V; Slaninová B Cesk Otolaryngol; 1977 Oct; 26(5):267-71. PubMed ID: 603948 [No Abstract] [Full Text] [Related]
6. [Otospongiosis, a cellular and lysosomal enzymatic disease; cyto-clinical comparison. II. E.N.G.-hydrolase correlation. Triple E.N.G.-C.O.-hydrolase correlations]. Causse J; Chevance LG; Bel J; Michaux P; Tapon J Ann Otolaryngol Chir Cervicofac; 1972; 89(10):563-95. PubMed ID: 4659633 [No Abstract] [Full Text] [Related]
7. Medical therapy of otospongiosis. Shambaugh GE Acta Otorhinolaryngol Belg; 1981; 35(5-6):390-403. PubMed ID: 7347082 [No Abstract] [Full Text] [Related]
8. Fluorides for otospongiosis and other osteoporotic states. Shambaugh GE Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):129-38. PubMed ID: 4717369 [No Abstract] [Full Text] [Related]
9. [Otospongiosis, a cellular and enzymatic lysosomal disease. Cyto-clinical correlation]. Chevance LG; Causse J; Jorgensen MB; Bretlau P Ann Otolaryngol Chir Cervicofac; 1972; 89(1):5-34. PubMed ID: 4537996 [No Abstract] [Full Text] [Related]
10. [Hydrogen ion concentration (pH) of the perilymph in otosclerosis patients]. Patiakina OK; Samsonov FA Zh Ushn Nos Gorl Bolezn; 1976; (5):83-4. PubMed ID: 11619 [No Abstract] [Full Text] [Related]
11. [Problem of labytrinthization inh surgery of otospongiosis]. Causse J; Bel J; Tapon J Ann Otolaryngol Chir Cervicofac; 1968; 85(1):35-55. PubMed ID: 5759938 [No Abstract] [Full Text] [Related]
14. [Protein spectrum in the perilymph in otosclerosis and other functional disorders of the inner and middle ear]. Chládek V; Opplt J Cas Lek Cesk; 1968; 107(37):1132-6. PubMed ID: 4176048 [No Abstract] [Full Text] [Related]
15. Ten years experience with fluoride in otosclerotic (otospongiotic) patients. Shambaugh GE; Causse J Ann Otol Rhinol Laryngol; 1974; 83(5):635-42. PubMed ID: 4416065 [No Abstract] [Full Text] [Related]
16. [Functional prognosis in otospongiosis surgery]. Sterkers JM Cah Coll Med Hop Paris; 1969 Nov; 10(14):1157-64. PubMed ID: 5364634 [No Abstract] [Full Text] [Related]
17. [Pathophysiology and treatment of otosclerosis. Use of sodium fluoride therapy]. Ivanović A; Mitrović M Vojnosanit Pregl; 1982; 39(2):95-9. PubMed ID: 7113022 [No Abstract] [Full Text] [Related]